Why Is RTX (RTX) Up 0.1% Since Last Earnings Report?

RTX Corporation exceeded second-quarter 2025 expectations, reporting adjusted EPS of $1.56, beating the $1.45 consensus, and sales of $21.58 billion, surpassing the $20.58 billion estimate, with growth across all segments. Despite this strong Q2 performance, the company revised its full-year 2025 guidance, lowering adjusted EPS to $5.80-$5.95 from $6.00-$6.15, while simultaneously raising its sales forecast to $84.75-$85.50 billion. This mixed outlook, combined with the stock's recent underperformance and a Zacks Rank #4 (Sell), suggests a tempered analyst sentiment despite the top-line strength.

Analysis

RTX Corporation reported a robust second quarter for 2025, exceeding analyst expectations on both revenue and earnings. Adjusted EPS came in at $1.56, a 7.6% beat over consensus and a 10.6% improvement year-over-year, while sales of $21.58 billion surpassed estimates by 5.1% with solid 9.4% year-over-year growth. This top-line strength was broad-based, with all three business segments—Collins Aerospace (+8.9%), Pratt & Whitney (+12.2%), and Raytheon (+6.4%)—posting significant sales increases. However, these strong operational results are overshadowed by a mixed full-year guidance and deteriorating cash flow metrics. The company lowered its 2025 adjusted EPS forecast to a range of $5.80-$5.95, down from $6.00-$6.15, while simultaneously raising its sales projection. This divergence signals anticipated margin pressure for the remainder of the year. Furthermore, free cash flow for the quarter plummeted to $0.72 billion from $2.07 billion in the prior-year period, a significant concern for liquidity and capital return. The market's muted reaction, with the stock gaining only 0.1% post-earnings and underperforming the S&P 500, reflects these forward-looking headwinds. The negative sentiment is reinforced by a downward trend in analyst estimate revisions and a Zacks Rank #4 (Sell), indicating that concerns over future profitability and cash generation are currently outweighing the strong quarterly performance.

Key Decisions for Investors

• Investors should exercise caution, as the company's lowered full-year EPS guidance despite a raised sales forecast points to significant margin compression ahead.
• The sharp year-over-year decline in free cash flow is a critical red flag; monitor the company's progress toward its full-year cash flow target of $7.0-$7.5 billion to assess operational health.
• Given the negative analyst sentiment, downward estimate revisions, and recent stock underperformance, it may be prudent to hold existing positions rather than initiate new ones until there is greater clarity on the margin and cash flow outlook.